AlphaYouSC
Congress trade
Sen. Susan Collins (R-ME) sold $1K-$15K of Celgene Corporation (NASDAQ) (CELG) stock
Susan Collins, U.S. Senator (R-ME), disclosed a sale of Celgene Corporation (NASDAQ) (CELG) stock worth $1K-$15K in a STOCK Act filing on Apr 1, 2014.
The trade happened on Mar 27, 2014, 5 days before it was made public.
- Traded
- Mar 27, 2014
- Disclosed
- Apr 1, 2014
- Filing delay
- 5 days
- Source
- STOCK Act disclosure
Other trades in this disclosure (3)
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.